Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA study by Sokka, Tuulikki, Kautiainen, Hannu, Pincus, Theodore, Verstappen, Suzanne M M, Aggarwal, Amita, Alten, Rieke, Andersone, Daina, Badsha, Humeira, Baecklund, Eva, Belmonte, Miguel, Craig-Müller, Jürgen, da Mota, Licia Maria Henrique, Dimic, Alexander, Fathi, Nihal A, Ferraccioli, Gianfranco, Fukuda, Wataru, Géher, Pál, Gogus, Feride, Hajjaj-Hassouni, Najia, Hamoud, Hisham, Haugeberg, Glenn, Henrohn, Dan, Horslev-Petersen, Kim, Ionescu, Ruxandra, Karateew, Dmitry, Kuuse, Reet, Laurindo, Ieda Maria Magalhaes, Lazovskis, Juris, Luukkainen, Reijo, Mofti, Ayman, Murphy, Eithne, Nakajima, Ayako, Oyoo, Omondi, Pandya, Sapan C, Pohl, Christof, Predeteanu, Denisa, Rexhepi, Mjellma, Rexhepi, Sylejman, Sharma, Banwari, Shono, Eisuke, Sibilia, Jean, Sierakowski, Stanislaw, Skopouli, Fotini N, Stropuviene, Sigita, Toloza, Sergio, Valter, Ivo, Woolf, Anthony, Yamanaka, Hisashi

Get full text

The human anti-IL-1 beta monoclonal antibody ACZ885 is effective in joint inflammation models in mice and in a proof-of-concept study in patients with rheumatoid arthritis by Alten, Rieke, Gram, Hermann, Joosten, Leo A, van den Berg, Wim B, Sieper, Joachim, Wassenberg, Siegfrid, Burmester, Gerd, van Riel, Piet, Diaz-Lorente, Maria, Bruin, Gerardus J M, Woodworth, Thasia G, Rordorf, Christiane, Batard, Yannik, Wright, Andrew M, Jung, Thomas

Get full text

The human anti-IL-1beta monoclonal antibody ACZ885 is effective in joint inflammation models in mice and in a proof-of-concept study in patients with rheumatoid arthritis by Rieke Alten, Gram, Hermann, Joosten, Leo A, Wim B van den Berg, Sieper, Joachim, Wassenberg, Siegfrid, Burmester, Gerd, Piet van Riel, Diaz-Lorente, Maria, Bruin, Gerardus J M, Woodworth, Thasia G, Rordorf, Christiane, Batard, Yannik, Wright, Andrew M, Jung, Thomas

Get full text